[Congress] European Association of Nuclear Medicine Annual Meeting - 12-16 October - Barcelona - Spain

EANM 2019 Oncodesign

Oncodesign participates for the first time with its partner Chematech at the annual conference of the EANM!

This is the opportunity to present our offer on the pre-clinical evaluation of your targeted radiotherapy: a unique combination of our skills in radiochemistry and in vivo pharmaco-imaging.

Come and discover this offer on our [Stand 34]. Cyril Berthet, Director of the Pharmaco-Imaging Unit, and Emilie Soulier, Sales Manager, will welcome you to discuss your imaging projects.

Schedule an appointment to discover how Oncodesign can accelerate the progress of your pipeline!

This email address is being protected from spambots. You need JavaScript enabled to view it.

[Congress] GMP Annual Symposium – 16-18 October - Lyon - France

GMP 2019 Oncodesgin

Join our team during this event dedicated to metabolism and pharmacokinetics!

Dr. Mouhssin Oufir, Director of the DMPK Unit and Bioanalyses, will present his poster on the quantification of membrane proteins. A unique opportunity to discover our exclusive MS2Plex® solution.

[POSTER] « Quantitative Targeted Absolute Proteomics (QTAP) analysis of transporters for the validation of an in vitro Blood Brain Barrier model”

Cécile Oliviarius, Business Manager, will also be attending annual meeting to figure out your need in drug analysis.

I fix a meeting!

[Congress] AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – 26-30 October - Boston, USA

EORTC 2019 Oncodesign

Join Oncodesign in Boston during the Molecular Targets and Cancer Therapeutics Conference and discover our latest poster!

[POSTER] ”Investigation of immuno-oncology drugs with humanized mouse models: a panel of technologies to evaluate different pharmacological approaches”

How to speed up the proof of concept of your drug candidates?
Do not wait any longer to know all the possibilities that our R&D proposes to you! Our team of experts in oncology and immuno-oncology will be present with Caroline Mignard, study director, and Carol Gebert, Sales Manager.

This email address is being protected from spambots. You need JavaScript enabled to view it.

[Congress] ELRIG Drug Discovery – 5-6 November - Liverpool - UK

ELRIG 2019 Oncodesign

Are you looking for an innovative company that guides you in the development of your molecule from the early stages?

For over 25 years, we have been developing technology platforms to support translational research from the early stages of the Drug Discovery process - a real driver of innovation acceleration and success for your molecule.

Mike Brown - Sales Manager - will be there to listen to you and find out about our offerings in oncology, immunology, dermatology, inflammatory and infectious diseases.

Discover our expertise on the exclusive MS2Plex offering presented in the poster below:

[POSTER] « Quantitative Targeted Absolute Proteomics (QTAP) analysis of transporters for the validation of an in vitro Blood Brain Barrier model”

This email address is being protected from spambots. You need JavaScript enabled to view it.

By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.